scholarly journals Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1 ‐mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy protocols for AML given as a result of the COVID‐19 pandemic

2020 ◽  
Vol 190 (4) ◽  
Author(s):  
Nadine Farah ◽  
Richard Burt ◽  
Amr R. Ibrahim ◽  
Robert Baker ◽  
Panagiotis D. Kottaridis
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Disease Monitoring ◽  
Minimal Residual Disease Monitoring ◽  
Minimal Residual ◽  
Reduced Intensity ◽  
Acute Myeloid

Feasibility ofBAALCgene expression for detection of minimal residual disease and risk stratification in normal karyotype acute myeloid leukaemia

2016 ◽  
Vol 175 (5) ◽  
pp. 904-916 ◽  
Author(s):  
Simone Weber ◽  
Torsten Haferlach ◽  
Tamara Alpermann ◽  
Karolína Perglerová ◽  
Susanne Schnittger ◽  
...  
Keyword(s):  
Risk Stratification ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Normal Karyotype ◽  
Minimal Residual ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document